Gene · 5396
Papers1,667
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,667
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PRRX1-OLR1 axis supports CAFs-mediated lung cancer progression and immune suppression. | Cancer Cell Int | 2024 | 39010054 | PubTator, text mining | PubMed |
| PRRX1-fused mesenchymal neoplasm: A novel PRRX1::NCOA1 fusion transcript. | J Cutan Pathol | 2024 | 38986510 | PubTator, text mining | PubMed |
| PRRX1 silencing is required for metastatic outgrowth in melanoma and is an independent prognostic of reduced survival in patients. | Mol Oncol | 2024 | 38978350 | PubTator, text mining | PubMed |
| Propofol Protects the Blood-Brain Barrier After Traumatic Brain Injury by Stabilizing the Extracellular Matrix via Prrx1: From Neuroglioma to Neurotrauma. | Neurochem Res | 2024 | 38951281 | PubTator, text mining | PubMed |
| Taxonomy of introns and the evolution of minor introns. | Nucleic Acids Res | 2024 | 38943346 | PubTator, text mining | PubMed |
| Exploiting tertiary lymphoid structures gene signature to evaluate tumor microenvironment infiltration and immunotherapy response in colorectal cancer. | Front Oncol | 2024 | 38846981 | PubTator, text mining | PubMed |
| Exploring the Relevance of Disulfidptosis to the Pathophysiology of Ulcerative Colitis by Bioinformatics Analysis. | J Inflamm Res | 2024 | 38737111 | PubTator, text mining | PubMed |
| BMP signaling maintains auricular chondrocyte identity and prevents microtia development by inhibiting protein kinase A. | Elife | 2024 | 38690987 | PubTator, text mining | PubMed |
| PRRX1 upregulates PD-L1 in human mesenchymal stem cells. | In Vitro Cell Dev Biol Anim | 2024 | 38664281 | PubTator, text mining | PubMed |
| Coordination among frequent genetic variants imparts substance use susceptibility and pathogenesis. | Front Neurosci | 2024 | 38660223 | PubTator, text mining | PubMed |
| Retraction: miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer. | J Cell Mol Med | 2024 | 38655709 | PubTator, text mining | PubMed |
| Reciprocal negative feedback between Prrx1 and miR-140-3p regulates rapid chondrogenesis in the regenerating antler. | Cell Mol Biol Lett | 2024 | 38643083 | PubTator, text mining | PubMed |
| Identification and validation of PCDHGA12 and PRRX1 methylation for detecting lung cancer in bronchial washing sample. | Oncol Lett | 2024 | 38638845 | PubTator, text mining | PubMed |
| IL-17RA Signaling in Prx1+ Mesenchymal Cells Influences Fracture Healing in Mice. | Int J Mol Sci | 2024 | 38612562 | PubTator, text mining | PubMed |
| Effects of miR-330-3p on Invasion, Migration and EMT of Gastric Cancer Cells by Targeting PRRX1-Mediated Wnt/β-Catenin Signaling Pathway [Retraction]. | Onco Targets Ther | 2024 | 38595927 | PubTator, text mining | PubMed |
| Human split hand/foot variants are not as functional as wildtype human PRDM1 in the rescue of craniofacial defects. | Birth Defects Res | 2024 | 38456586 | PubTator, text mining | PubMed |
| PRRX1-TOP2A interaction is a malignancy-promoting factor in human malignant peripheral nerve sheath tumours. | Br J Cancer | 2024 | 38448751 | PubTator, text mining | PubMed |
| Skeletal stem cells in bone development, homeostasis, and disease. | Protein Cell | 2024 | 38442300 | PubTator, text mining | PubMed |
| Single-cell analysis identified POSTN+ cells associated with the aggressive phenotype and risk of esophageal squamous cell carcinoma. | HGG Adv | 2024 | 38369754 | PubTator, text mining | PubMed |
| PRX1-positive mesenchymal stem cells drive molar morphogenesis. | Int J Oral Sci | 2024 | 38369512 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5396/papers?page=6